Similar articles

• Effect of cefamandole nafate on blood coagulation and platelet function.

  Custer GM, Briggs BR, Smith RE. Custer GM, et al. Antimicrob Agents Chemother. 1979 Dec;16(6):869-72. doi: 10.1128/AAC.16.6.869. Antimicrob Agents Chemother. 1979. PMID: 533268 Free PMC article.
• Bioavailability and pain study of cefamandole nafate.

  Foster TS, Shrewsbury RP, Coonrod JD. Foster TS, et al. J Clin Pharmacol. 1980 Aug-Sep;20(8-9):526-33. doi: 10.1002/j.1552-4604.1980.tb02546.x. J Clin Pharmacol. 1980. PMID: 7000857 Clinical Trial.
• [Cefamandole nafate in short-term prophylaxis in obstetric and gynecologic surgery].

  Accardo FM, Mancuso A, Granese D, Dugo C. Accardo FM, et al. Minerva Ginecol. 1983 May;35(5):351-6. Minerva Ginecol. 1983. PMID: 6877656 Italian. No abstract available.
• [Effect of thrombolytic agents on platelets and blood coagulation system].

  Suehiro A. Suehiro A. Rinsho Byori. 1997 Oct;45(10):951-6. Rinsho Byori. 1997. PMID: 9369072 Review. Japanese.
• [Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].

  Pastorova VE, Liapina LA, Cherkasova KA, Ashmarin IP. Pastorova VE, et al. Usp Fiziol Nauk. 1999 Apr-Jun;30(2):80-91. Usp Fiziol Nauk. 1999. PMID: 10420478 Review. Russian.